Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early health technology assessment of gene silencing therapies for lowering lipoprotein(a) in the secondary prevention of coronary heart disease

31 Aug 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Interventions and Diagnostics
Share to Lipoproteins and Cardiovascular Health
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39322524
DOI: 10.1016/j.jacl.2024.08.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early health technology assessment of gene silencing therapies for lowering lipoprotein(a) in the secondary prevention of coronary heart diseasePMID 39322524Read ↗

Gene-based therapy in lipid management: the winding road from promise to practiceSemantic proximity Read ↗

The Role of Antisense Oligonucleotide Therapy in Patients with Familial Hypercholesterolemia: Risks, Benefits, and Management RecommendationsSemantic proximity Read ↗

Established and Emerging Nucleic Acid Therapies for Familial HypercholesterolemiaSemantic proximity Read ↗

A new dawn for managing dyslipidemias: The era of rna-based therapiesSemantic proximity Read ↗

Lipid nanoparticle delivery of TALEN mRNA targeting LPA causes gene disruption and plasma lipoprotein(a) reduction in transgenic miceSemantic proximity Read ↗

Advances in nucleic acid-targeted therapies for cardiovascular disease preventionSemantic proximity Read ↗

The Promise of PCSK9 and Lipoprotein(a) as Targets for Gene Silencing TherapiesSemantic proximity Read ↗

Weekly journal scan: a new small-interfering RNA to fight a genetic cardiovascular risk factor.Semantic proximity Read ↗

Lipoprotein(a): more interesting than ever after 50 years.Semantic proximity Read ↗

Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?Semantic proximity Read ↗

Advances in biological therapies for dyslipidemias and atherosclerosisSemantic proximity Read ↗

Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart AssociationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.